FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/01/030757 [Registered on: 27/01/2021] Trial Registered Prospectively
Last Modified On: 20/01/2021
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Assessment of knowledge, attitude and practices about cancer and its treatment and prferences about cancer treatment in urological cancer patients seeking treatment at Tata Memorial Hospital 
Scientific Title of Study   Prospective study to assess the impact of patients’ Knowledge, Attitude and Practices about cancer on the Stage At Presentation for seeking cancer treatment at the hospital, among patients registered with the Out Patient Department of the Uro-oncology Disease Management Group at Tata Memorial Hospital (KAP-SAP study) 
Trial Acronym  KAP-SAP 
Secondary IDs if Any  
Secondary ID  Identifier 
3627  Other 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ganesh Bakshi 
Designation  Professor, Dept of Surgical Oncology 
Affiliation  Tata Memorial Hospital 
Address  OPD 224, HBB, Tata Memorial Hospital, Dr E Borges Marg, Parel, Mumbai
Dr E Borges Marg, Parel, Mumbai Postal code: 400012
Mumbai (Suburban)
MAHARASHTRA
400012
India 
Phone  02224176228  
Fax    
Email  gkbakshi73uro@hotmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ganesh Bakshi 
Designation  Professor, Dept of Surgical Oncology 
Affiliation  Tata Memorial Hospital 
Address  OPD 224, HBB, Tata Memorial Hospital, Dr E Borges Marg, Parel, Mumbai
Dr E Borges Marg, Parel, Mumbai Postal code: 400012
Mumbai (Suburban)
MAHARASHTRA
400012
India 
Phone  02224176228  
Fax    
Email  gkbakshi73uro@hotmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ganesh Bakshi 
Designation  Professor, Dept of Surgical Oncology 
Affiliation  Tata Memorial Hospital 
Address  OPD 224, HBB, Tata Memorial Hospital, Dr E Borges Marg, Parel, Mumbai
Dr E Borges Marg, Parel, Mumbai Postal code: 400012
Mumbai (Suburban)
MAHARASHTRA
400012
India 
Phone  02224176228  
Fax    
Email  gkbakshi73uro@hotmail.com  
 
Source of Monetary or Material Support  
Tata Memorial Hospital, Dr E Borges Marg, Parel, Mumbai, Postal Code: 400012 
 
Primary Sponsor  
Name  Nil 
Address  Nil 
Type of Sponsor  Other [Nil] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ganesh Bakshi  Tata Memorial Hospital  HBB OPD 222-225, GJB OPD 501-503, Uro-oncology DMG, Tata Memorial Hospital, Dr E Borges Marg, PArel, Mumbai 400012
Mumbai (Suburban)
MAHARASHTRA 
02224176228

gkbakshi73uro@hotmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C67||Malignant neoplasm of bladder, (2) ICD-10 Condition: C64||Malignant neoplasm of kidney, except renal pelvis, (3) ICD-10 Condition: C68||Malignant neoplasm of other and unspecified urinary organs,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Not Applicable  Not Applicable 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  1. New registered patients presenting to Uro-oncology DMG.
2. All adult patients
3. Patients with atleast one consenting adult accompanying person
4. The any consenting accompanying person must necessarily be an adult. The consenting adult accompanying person must necessarily be a literate in cases where patient is illiterate.
5. Patients who are willing to give the informed consent.
 
 
ExclusionCriteria 
Details  1. The consenting adult accompanying person is an not an adult or is an illiterate in cases where the patient is illiterate.
2. The consenting adult accompanying refuses to assist the patient, in cases where the patient is illiterate.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To evaluate the association of patients’ knowledge, attitude and practices (KAP) of cancer and cancer management, at initial hospital visit, on their cancer stage at presentation at theUro-oncology DMG, Tata Memorial Hospital to seek cancer treatment.  6 months 
 
Secondary Outcome  
Outcome  TimePoints 
To determine the association of patients’ cancer related KAP at initial hospital visit, with the compliance to first definitive treatment. [Compliance to advised treatment may be anyone of the following: undergoing the treatment procedure or taking the treatment as prescribed (doses and time)]
 
6 months 
To determine the socio-economic and demographic factors influencing the knowledge, attitude and practices among the patients presenting at the Urooncology DMG, Tata Memorial Hospital.
 
6 months 
To determine the socio-economic and demographic factors influencing the treatment related preferences among the patients presenting at the Urooncology DMG, Tata Memorial Hospital.
 
6 months 
To determine patients’ cancer treatment related preferences, at two different time points, first at the first visit at Tata Memorial hospital and for the second time after first treatment planning consultation with the doctor.
 
6 months 
To evaluate the impact of doctors’ consultation on the treatment preferences of the patient. This will be done by comparing the patients’ treatment preferences at both the time points  6 months 
To compare the association of the patients’ cancer treatment related preferences at both the time points with the patient’s compliance to the first definitive treatment  6 months 
To evaluate the association of patient’s knowledge, attitude and practices (KAP) of cancer and cancer management, at initial hospital visit, on the patient’s cancer stage at presentation at the Uro-oncology DMG, Tata Memorial Hospital to seek cancer treatment  6 months 
 
Target Sample Size   Total Sample Size="256"
Sample Size from India="256" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   27/01/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   No publications yet. 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Cancer is a growing concern worldwide. There has been an increasing trend in the cancer cases, with nearly 50% of the new cases and a little more than 50% of cancer deaths being reported from Asia. According to WHO, approximately 70% of deaths from cancer occur in low-and middle-income countries, and around one third of deaths from cancer are due to modifiable behavioral and dietary risks. There is a varied pattern of awareness about cancer in the Indian population and this is affected by the socio-demographic characteristics as well. Overall, the awareness about cancer, its risk factors, symptoms, treatment measures, preventive measures has been low. Early detection of cancer facilitates better outcomes, improved survival, less morbidity and less expensive treatment. A study in Puducherry, South India found that there was a low level of awareness of common cancers among adults. General awareness of cancer and also about its curability, preventability and screening methods is poor among the Indian population. KAP of the patient and family members knowledge, attitudes and practices (KAP) about cancer and its treatment play an important role in influencing the healthcare seeking behavior among cancer patients and the patient’s compliance to diagnosis and treatment.
The studies to asses cancer related KAP have largely been conducted in the communities. There are very few hospital-based studies on this subject. To the best of our knowledge there are no studies conducted to assess the KAP of Urological cancers. We hypothesize that the cancer related knowledge, attitude, and practices (KAP) influences the patient’s cancer care seeking behaviour.
 
Close